ADENOCARCINOMA OF SALIVARY GLAND

ADENOCARCINOMA OF SALIVARY GLAND was reported 39 times

ADENOCARCINOMA OF SALIVARY GLAND is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1 0.0000
1 Phosphodiesterase 4 Inhibitor [EPC] 6 0.0000
2 Platinum-based Drug [EPC] 9 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 8 0.0000
4 Interleukin-17A Antagonist [EPC] 1 0.0000
5 Aminoglycoside Antibacterial [EPC] 1 0.0000
6 Kinase Inhibitor [EPC] 12 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
8 Proteasome Inhibitor [EPC] 2 0.0000
9 Androgen Receptor Inhibitor [EPC] 1 0.0000
10 HER2/neu Receptor Antagonist [EPC] 1 0.0000
11 Integrin Receptor Antagonist [EPC] 1 0.0000
12 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
13 Purine Antimetabolite [EPC] 1 0.0000
14 Interleukin-12 Antagonist [EPC] 1 0.0000
15 Interleukin-23 Antagonist [EPC] 1 0.0000
16 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
17 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
18 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
19 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
20 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
21 Vitamin D [EPC] 2 0.0000
22 Vitamin B12 [EPC] 2 0.0000
23 Microtubule Inhibitor [EPC] 1 0.0000
24 RANK Ligand Inhibitor [EPC] 1 0.0000
25 Vitamin C [EPC] 2 0.0000
26 Alkylating Drug [EPC] 1 0.0000
27 Corticosteroid [EPC] 5 0.0000
28 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
29 Thalidomide Analog [EPC] 2 0.0000
30 Opioid Agonist [EPC] 1 0.0000
31 Factor Xa Inhibitor [EPC] 1 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
34 Insulin Analog [EPC] 1 0.0000
35 Loop Diuretic [EPC] 1 0.0000
36 Platelet Aggregation Inhibitor [EPC] 1 0.0000